Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivo evidence
2011

Equol and Prostate Health

Sample size: 16 publication 10 minutes Evidence: moderate

Author Information

Author(s): Trent D Lund, Crystal Blake, Lihong Bu, Amy N Hamaker, Edwin D Lephart

Primary Institution: Brigham Young University

Hypothesis

Does equol have beneficial effects on prostate health by binding to 5alpha-dihydrotestosterone (5alpha-DHT)?

Conclusion

Equol administration may improve prostate health by reducing PSA levels and prostate size without affecting other hormone levels.

Supporting Evidence

  • Equol significantly decreased serum 5alpha-DHT levels in treated rats.
  • Equol reduced prostate weights in male rats without altering testosterone or LH levels.
  • Equol blocked the increase in PSA levels in human prostate cancer cells stimulated by 5alpha-DHT.

Takeaway

Equol is a natural compound that can help keep the prostate healthy by blocking a hormone that can cause problems.

Methodology

The study involved in vitro binding assays and in vivo experiments with rats to assess the effects of equol on prostate health.

Limitations

The study was conducted on rats, and results may not directly translate to humans.

Participant Demographics

Adult male Long-Evans rats were used in the study.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1477-7827-9-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication